Mono-dysplasia score based on automated cell counter (Sysmex) – A novel parameter for differentiating reactive monocytosis from hematological malignancies

INTRODUCTION: In India, there is a high burden of infections such as tuberculosis, dengue, and malaria which are common causes of monocytosis. This increases the workload of smear examination by the pathologist. “Mono-dysplasia score” is obtained with a simple complete blood count on an automated ce...

Full description

Bibliographic Details
Main Authors: Priyanka Moule, Sabina Langer, Nitin Gupta, Jyoti Kotwal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Journal of Applied Hematology
Subjects:
Online Access:http://www.jahjournal.org/article.asp?issn=1658-5127;year=2023;volume=14;issue=3;spage=187;epage=193;aulast=Moule
_version_ 1797649214497357824
author Priyanka Moule
Sabina Langer
Nitin Gupta
Jyoti Kotwal
author_facet Priyanka Moule
Sabina Langer
Nitin Gupta
Jyoti Kotwal
author_sort Priyanka Moule
collection DOAJ
description INTRODUCTION: In India, there is a high burden of infections such as tuberculosis, dengue, and malaria which are common causes of monocytosis. This increases the workload of smear examination by the pathologist. “Mono-dysplasia score” is obtained with a simple complete blood count on an automated cell counter and includes the parameters neutrophil (Ne) and monocyte (Mo) count and Ne-WX which is a Ne dispersion parameter. It is operator independent, objective, and does not require a high level of expertise. AIMS: The aims of the study were to assess the utility of Monoscore/mono-dysplasia score calculated using research parameters of Sysmex XN automated cell counter, as a screening tool for differentiating reactive monocytosis from hematological malignancies associated with monocytosis. MATERIALS AND METHODS: Samples sent in EDTA vacutainer for routine hemogram fulling the criteria for monocytosis (WHO criteria – absolute monocyte count ≥1 × 109/L and accounting for ≥10% of the total white blood cell count) were included in the study. Monoscore was calculated using the formula established by Schillinger et al. Flow cytometry, bone marrow examination, etc., were done as and when needed as standard-of-care tests to establish a final diagnosis. RESULTS: One thousand two hundred and fifty-seven samples were analyzed out of which 41 samples were chronic myelomonocytic leukemia and 126 were other hematological malignancies (HD) including acute leukemias, myelodysplastic syndrome, myeloproliferative neoplasm, etc. Using receiver operating characteristics curves, we established the cutoff 0.212 which showed a sensitivity of 97.6% and specificity of 96.4% to differentiated reactive monocytosis form HD. CONCLUSIONS: A sample showing monocytosis and Monoscore <0.212 and without any other flags can be safely auto-authorized without peripheral blood smears examination, reducing the burden of slides to be reviewed.
first_indexed 2024-03-11T15:43:02Z
format Article
id doaj.art-4877e6e0106f4d97abff5865fcb9c25b
institution Directory Open Access Journal
issn 1658-5127
language English
last_indexed 2024-03-11T15:43:02Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Applied Hematology
spelling doaj.art-4877e6e0106f4d97abff5865fcb9c25b2023-10-26T08:50:41ZengWolters Kluwer Medknow PublicationsJournal of Applied Hematology1658-51272023-01-0114318719310.4103/joah.joah_54_23Mono-dysplasia score based on automated cell counter (Sysmex) – A novel parameter for differentiating reactive monocytosis from hematological malignanciesPriyanka MouleSabina LangerNitin GuptaJyoti KotwalINTRODUCTION: In India, there is a high burden of infections such as tuberculosis, dengue, and malaria which are common causes of monocytosis. This increases the workload of smear examination by the pathologist. “Mono-dysplasia score” is obtained with a simple complete blood count on an automated cell counter and includes the parameters neutrophil (Ne) and monocyte (Mo) count and Ne-WX which is a Ne dispersion parameter. It is operator independent, objective, and does not require a high level of expertise. AIMS: The aims of the study were to assess the utility of Monoscore/mono-dysplasia score calculated using research parameters of Sysmex XN automated cell counter, as a screening tool for differentiating reactive monocytosis from hematological malignancies associated with monocytosis. MATERIALS AND METHODS: Samples sent in EDTA vacutainer for routine hemogram fulling the criteria for monocytosis (WHO criteria – absolute monocyte count ≥1 × 109/L and accounting for ≥10% of the total white blood cell count) were included in the study. Monoscore was calculated using the formula established by Schillinger et al. Flow cytometry, bone marrow examination, etc., were done as and when needed as standard-of-care tests to establish a final diagnosis. RESULTS: One thousand two hundred and fifty-seven samples were analyzed out of which 41 samples were chronic myelomonocytic leukemia and 126 were other hematological malignancies (HD) including acute leukemias, myelodysplastic syndrome, myeloproliferative neoplasm, etc. Using receiver operating characteristics curves, we established the cutoff 0.212 which showed a sensitivity of 97.6% and specificity of 96.4% to differentiated reactive monocytosis form HD. CONCLUSIONS: A sample showing monocytosis and Monoscore <0.212 and without any other flags can be safely auto-authorized without peripheral blood smears examination, reducing the burden of slides to be reviewed.http://www.jahjournal.org/article.asp?issn=1658-5127;year=2023;volume=14;issue=3;spage=187;epage=193;aulast=Mouleautomated analyzerchronic myelomonocytic leukemiamonocytosis
spellingShingle Priyanka Moule
Sabina Langer
Nitin Gupta
Jyoti Kotwal
Mono-dysplasia score based on automated cell counter (Sysmex) – A novel parameter for differentiating reactive monocytosis from hematological malignancies
Journal of Applied Hematology
automated analyzer
chronic myelomonocytic leukemia
monocytosis
title Mono-dysplasia score based on automated cell counter (Sysmex) – A novel parameter for differentiating reactive monocytosis from hematological malignancies
title_full Mono-dysplasia score based on automated cell counter (Sysmex) – A novel parameter for differentiating reactive monocytosis from hematological malignancies
title_fullStr Mono-dysplasia score based on automated cell counter (Sysmex) – A novel parameter for differentiating reactive monocytosis from hematological malignancies
title_full_unstemmed Mono-dysplasia score based on automated cell counter (Sysmex) – A novel parameter for differentiating reactive monocytosis from hematological malignancies
title_short Mono-dysplasia score based on automated cell counter (Sysmex) – A novel parameter for differentiating reactive monocytosis from hematological malignancies
title_sort mono dysplasia score based on automated cell counter sysmex a novel parameter for differentiating reactive monocytosis from hematological malignancies
topic automated analyzer
chronic myelomonocytic leukemia
monocytosis
url http://www.jahjournal.org/article.asp?issn=1658-5127;year=2023;volume=14;issue=3;spage=187;epage=193;aulast=Moule
work_keys_str_mv AT priyankamoule monodysplasiascorebasedonautomatedcellcountersysmexanovelparameterfordifferentiatingreactivemonocytosisfromhematologicalmalignancies
AT sabinalanger monodysplasiascorebasedonautomatedcellcountersysmexanovelparameterfordifferentiatingreactivemonocytosisfromhematologicalmalignancies
AT nitingupta monodysplasiascorebasedonautomatedcellcountersysmexanovelparameterfordifferentiatingreactivemonocytosisfromhematologicalmalignancies
AT jyotikotwal monodysplasiascorebasedonautomatedcellcountersysmexanovelparameterfordifferentiatingreactivemonocytosisfromhematologicalmalignancies